Tumour-induced immune modulation of sentinel lymph nodes, Nat. Rev. Immunol, vol.6, pp.659-670, 2006. ,
The tumor-draining lymph node as an immuneprivileged site, Immunol. Rev, vol.213, pp.146-158, 2006. ,
Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction, Immunity, vol.28, pp.687-697, 2008. ,
Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer -authors' reply, Lancet Oncol, vol.14, pp.251-252, 2013. ,
Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (Alliance) randomized clinical trial, JAMA, vol.318, p.918, 2017. ,
Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity, Nat. Rev. Cancer, vol.12, pp.210-219, 2012. ,
Growth and immune evasion of lymph node metastasis, Front. Oncol, vol.8, p.36, 2018. ,
Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes, Immunol. Lett, vol.158, pp.57-65, 2014. ,
Human secondary lymphoid organs typically contain polyclonally-activated proliferating regulatory T cells, Blood, vol.122, pp.2213-2223, 2013. ,
Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer, Breast Cancer Res, vol.6, p.408, 2004. ,
Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients, Int. J. Cancer, vol.132, pp.2537-2547, 2013. ,
Regulatory T cells exhibit distinct features in human breast cancer, Immunity, vol.45, pp.1122-1134, 2016. ,
Regulatory T cells in the tumor microenvironment and cancer progression: role and therapeutic targeting, Vaccines (Basel), vol.4, p.28, 2016. ,
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at rsk of late relapse, JCO, vol.24, pp.5373-5380, 2006. ,
FOXP3 expression and overall survival in breast cancer, JCO, vol.27, pp.1746-1752, 2009. ,
Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells, Blood, vol.119, pp.4430-4440, 2012. ,
Identity and diversity of human peripheral Th and T regulatory cells defined by single-cell mass, Cytom. J. I, vol.200, pp.336-346, 2018. ,
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node, J. Immunother. Cancer, vol.7, p.133, 2019. ,
Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer, PLoS Med, vol.2, p.284, 2005. ,
Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer, Eur. J. Cancer, vol.45, pp.2123-2131, 2009. ,
Cancer immunotherapy: beyond checkpoint blockade, Annu. Rev. Cancer Biol, vol.3, pp.55-75, 2019. ,
Clonal replacement of tumor-specific T cells following PD-1 blockade, Nat. Med, vol.25, pp.1251-1259, 2019. ,
Current landscape of immunotherapy in breast cancer: a review, JAMA Oncol, vol.5, p.1205, 2019. ,
Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells, Clin. Cancer Res, vol.16, pp.3485-3494, 2010. ,
Connecting blood and intratumoral Treg cell activity in predicting future relapse in breast cancer, Nat. Immunol, vol.20, pp.1220-1230, 2019. ,
Oncology meets immunology: the cancer-immunity cycle, Immunity, vol.39, pp.1-10, 2013. ,
Leukocyte composition of human breast cancer, Proc. Natl Acad. Sci, vol.109, pp.2796-2801, 2012. ,
Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor, Immunity, vol.30, pp.899-911, 2009. ,
Regulatory T cells in cancer immunotherapy, Curr. Opin. Immunol, vol.27, pp.1-7, 2014. ,
Antigen-independent accumulation of activated effector/ memory T lymphocytes into human and murine tumors, Int. J. Cancer, vol.118, pp.1205-1214, 2006. ,
Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease, Nat. Med, vol.17, pp.673-675, 2011. ,
Interferon-? drives T reg fragility to promote anti-tumor immunity, Cell, vol.169, p.11, 2017. ,
Foxp3+ regulatory T cells: differentiation, specification, subphenotypes, Nat. Immunol, vol.10, pp.689-695, 2009. ,
The who's who of T-cell differentiation: human memory T-cell subsets: HIGHLIGHTS, Eur. J. Immunol, vol.43, pp.2797-2809, 2013. ,
The different T-cell receptor repertoires in breast cancer tumors, draining lymph nodes, and adjacent tissues, Cancer Immunol. Res, vol.5, pp.148-156, 2017. ,
Thymic and peripheral differentiation of regulatory T cells, Adv. Immunol, vol.112, pp.25-71, 2011. ,
Transcriptional regulation and development of regulatory T cells, Exp. Mol. Med, vol.50, p.456, 2018. ,
Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node, Nat. Commun, vol.9, p.2113, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01976612
Antibodies to costimulatory receptor 4-1bb enhance antitumor immunity via T regulatory cell depletion and promotion of CD8 T cell effector function, Immunity, vol.49, 2018. ,
Aberrant frequency of TNFR2 + Treg and related cytokines in patients with CIN and cervical cancer, Oncotarget, vol.9, pp.5073-5083, 2018. ,
IL-33 increases ST2 + Tregs and promotes metastatic tumour growth in the lungs in an amphiregulin-dependent manner, OncoImmunology, vol.8, p.1527497, 2019. ,
The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer, Mucosal Immunol, vol.12, pp.990-1003, 2019. ,
FOXP3 and CEACAM6 expression and T cell infiltration in the occurrence and development of colon cancer, Oncol. Lett, vol.11, pp.3693-3701, 2016. ,
Trogocytosis of CD80 and CD86 by induced regulatory T cells, Cell Mol. Immunol, vol.9, pp.136-146, 2012. ,
CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells, Sci. Immunol, vol.4, p.902, 2019. ,
PD-L1:CD80 cis-heterodimer triggers the co-stimulatory receptor CD28 while repressing the inhibitory PD-1 and CTLA-4 pathways, Immunity, vol.51, pp.1059-1073, 2019. ,
Increase of regulatory T cells in the peripheral blood of cancer patients, Clin. Cancer Res, vol.9, pp.606-612, 2003. ,
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma, J. Immunol, vol.169, pp.2756-2761, 2002. ,
PD-1+ immune cell infiltration inversely correlates with survival of operable breast cancer patients, Cancer Immunol. Immunother, vol.63, pp.395-406, 2014. ,
The numbers of FoxP3+ lymphocytes in sentinel lymph nodes of breast cancer patients correlate with primary tumor size but not nodal status, Cancer Investig, vol.29, pp.419-425, 2011. ,
Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo, Nat. Immunol, vol.10, pp.1000-1007, 2009. ,
Treg fragility: a prerequisite for effective antitumor immunity?, Cancer Immunol. Res, vol.6, pp.882-887, 2018. ,
Impact of tumour microenvironment and Fc receptors on the activity of immunomodulatory antibodies, Trends Immunol, vol.35, pp.290-298, 2014. ,
Development of immune checkpoint therapy for cancer, J. Exp. Med, vol.216, pp.1244-1254, 2019. ,
The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy, Blood, vol.131, pp.39-48, 2018. ,
CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity, Cancer Res, vol.72, pp.4351-4360, 2012. ,
Adoptive cell transfer as personalized immunotherapy for human cancer, Science, vol.348, pp.62-68, 2015. ,
Towards personalized, tumour-specific, therapeutic vaccines for cancer, Nat. Rev. Immunol, vol.18, pp.168-182, 2018. ,
CD4 + follicular helper T cell infiltration predicts breast cancer survival, J. Clin. Invest, vol.123, pp.2873-2892, 2013. ,
T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire, Proc. Natl Acad. Sci. USA, vol.114, pp.10409-10417, 2017. ,
Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR, Nat. Immunol, vol.19, pp.291-301, 2018. ,
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor, Nat. Immunol, vol.18, pp.1332-1341, 2017. ,
Regulatory circuits of T cell function in cancer, Nat. Rev. Immunol, vol.16, pp.599-611, 2016. ,
Acquisition of CD80 by human T cells at early stages of activation: functional involvement of CD80 acquisition in T cell to T cell interaction, J. Immunol, vol.169, pp.6162-6169, 2002. ,
Transcriptome profiling of human FoxP3+ regulatory T cells, Hum. Immunol, vol.77, pp.201-213, 2016. ,
, Neoantigens in cancer immunotherapy. Science, vol.348, pp.69-74, 2015.
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer, Nat. Med, vol.24, pp.724-730, 2018. ,
CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets, vol.6, p.748, 2017. ,
Linking T-cell receptor sequence to functional phenotype at the single-cell level, Nat. Biotechnol, vol.32, pp.684-692, 2014. ,
MiXCR: software for comprehensive adaptive immunity profiling, Nat. Methods, vol.12, pp.380-381, 2015. ,